U.S. Personal Products Stock News

Martin Marietta Materials reported its fourth-quarter and full-year 2025 results on 11 February 2026, with sales rising to US$1,534 million for the quarter and US$6.15 billion for the year, while net income and earnings per share declined year on year, and it also updated investors with new 2026 revenue and earnings guidance. On the same day, the company completed a long-running share repurchase program first announced in 2015 and announced that George F. Schoen, a highly decorated M&A...

Quest Diagnostics (DGX) is back in focus after a busy February 10 update, combining higher quarterly and full year 2025 earnings, fresh 2026 guidance, a 7.5% dividend increase, and a larger share repurchase authorization. See our latest analysis for Quest Diagnostics. Those earnings, acquisition plans, dividend lift and larger buyback sit against a share price of $206.87, with a 7 day share price return of 8.2% and a 90 day share price return of 11.6%, while the 5 year total shareholder...

Why Apogee Therapeutics Is On Investors’ Radar Today Apogee Therapeutics (APGE) has been drawing attention after sharp moves in its share price in recent weeks, prompting investors to reassess how its clinical stage respiratory and inflammatory disease pipeline lines up with current market expectations. See our latest analysis for Apogee Therapeutics. At a share price of $67.78, Apogee Therapeutics has seen a mix of sharp moves recently, with a 9.1% 7 day share price return, a 16.1% 30 day...

NGL Energy Partners LP recently reported past third-quarter fiscal 2025 results showing higher net income and a shift to earnings per share profitability despite lower revenue, while also completing a share repurchase of 8,401,351 units for US$46.72 million. Shortly after, the partnership filed a US$121.3 million shelf registration for 10,000,000 common units under an ESOP-related offering, signaling an effort to balance employee ownership incentives with expanded capital flexibility. We...

Universal Health Services, Inc. recently announced that its Board of Directors approved a cash dividend of US$0.20 per share, paid on March 16, 2026 to shareholders of record as of March 2, 2026. This dividend decision comes alongside a period of strong earnings growth and ongoing expansion in acute care and behavioral health operations, highlighting management’s confidence in the business. We’ll now examine how the new dividend payment, together with robust earnings growth, could influence...

Enpro (NPO) is drawing investor attention after several board members reported insider share purchases around the same time the company announced a 3.2% increase in its quarterly dividend to $0.32 per share. See our latest analysis for Enpro. Those insider buys and the higher dividend come after a strong run in the share price, with a 30 day share price return of 12.03% and a 90 day share price return of 34.60%. The 1 year total shareholder return of 42.18% and 5 year total shareholder return...

In February 2026, Hasbro used its return to the North American International Toy Fair in New York to unveil a wide slate of new products and licensing collaborations across brands such as Peppa Pig, Monopoly, Beyblade, Nerf, Transformers, Star Wars, and an upcoming Harry Potter partnership starting in 2027. The combination of inclusive character storytelling, new nostalgia-driven launches like Crossfire, and cross-media deals tied to franchises such as Voltron positions Hasbro to further...

Duke Energy (DUK) shares are in focus after the company reported fourth quarter and full year 2025 results, with full year revenue of US$32.24b and net income of US$4.97b. See our latest analysis for Duke Energy. Duke Energy’s recent earnings release has coincided with improving momentum, with a 1 day share price return of 1.66%, a 1 month share price return of 7.53%, and a 1 year total shareholder return of 18.94%. This suggests investors are responding to steady financial progress and...

In early February 2026, Flex Ltd. reported third-quarter 2025 sales of US$7,058 million and nine-month sales of US$20,437 million, alongside lower quarterly net income but slightly higher year-to-date net income versus the prior year, and raised its fiscal 2026 net sales guidance to a range of US$27.2 billion to US$27.5 billion while confirming fourth-quarter 2026 guidance of US$6.75 billion to US$7.05 billion in net sales. An interesting angle for investors is that management is...

Earlier this week, Ovintiv Inc. was affected by a Scotiabank rating shift on the S&P/TSX index, altering how the company is grouped within institutional energy sector frameworks. This change in brokerage classification matters because it can influence how large investors benchmark Ovintiv against peers and adjust sector allocations. Next, we’ll examine how Scotiabank’s revised sector classification could shape Ovintiv’s broader investment narrative and institutional appeal. Uncover the next...

In early February 2026, Camden Property Trust reported higher fourth-quarter and full-year 2025 earnings, recorded a US$12,916,000 land-related impairment, issued 2026 EPS guidance of US$0.22–US$0.26 for the first quarter and US$0.40–US$0.70 for the year, raised its quarterly dividend to US$1.06 per share, and authorized up to US$600,000,000 of new share repurchases. Taken together, stronger reported profitability, a larger dividend, and fresh buyback capacity point to management’s current...

In early February 2026, Ford Motor reported full-year 2025 revenue of US$187,267 million but swung to a net loss of US$8,182 million, while also outlining 2026 guidance and confirming plans for additional combustion-powered and electric utes, including a new mid-size EV truck targeted around US$30,000. Alongside this weak profitability and tariff-related headwinds, Ford filed a universal shelf registration and continued investing in its Ford+ plan, signaling it may balance short-term...

CBL & Associates Properties recently reported fourth-quarter and full-year 2025 results showing higher revenue and net income versus the prior year, alongside 2026 earnings guidance and confirmation of its regular cash dividend for the quarter ended March 31, 2026. Beyond the headline numbers, the company highlighted balance sheet improvements, selective asset sales, and acquisitions of four dominant enclosed malls, signaling an emphasis on reshaping its retail real estate portfolio. Next,...

In February 2026, LuxExperience B.V. reported second-quarter sales of €646.92 million and a net loss of €12.64 million, while also updating full-year 2026 guidance to target GMV between €2.5 billion and €2.7 billion under its ongoing transformation plan. The combination of strong year-on-year sales growth and tighter guidance ranges highlights management’s confidence in executing its operational overhaul despite continued losses. With LuxExperience tightening full-year GMV guidance, we’ll...

Illinois Tool Works Inc. recently reported fourth-quarter 2025 results showing higher sales of US$4,093 million and net income of US$790 million year-on-year, while also detailing full-year 2025 performance and share repurchases totaling US$3.01 billions since August 2023. In addition, the company declared a first-quarter 2026 dividend of US$1.61 per share, equivalent to US$6.44 on an annualized basis, underscoring its continued emphasis on returning cash to shareholders through both...

Rush Street Interactive (RSI) is back in focus after CEO Richard Todd Schwartz sold 247,114 shares on February 4, trimming his direct stake to about 0.97% ahead of the upcoming Q4 FY2025 earnings release. See our latest analysis for Rush Street Interactive. At a share price of US$16.03, Rush Street Interactive has seen momentum cool recently, with a 30 day share price return of 16.94% and a year to date share price return of 16.99%, even though the 3 year total shareholder return sits at a...

Crane (CR) is back in focus after a quarterly operating update that detailed segment performance, manufacturing efficiency, and a routine distribution announcement, prompting investors to reassess the stock following a strong multiyear total return profile. See our latest analysis for Crane. At a share price of $200.52, Crane’s 90 day share price return of 11.72% and year to date share price return of 6.93% sit alongside a 1 year total shareholder return of 17.54% and very strong multi year...

Azenta stock performance snapshot after recent moves Azenta (AZTA) has seen mixed returns recently, with the share price up 1.8% over the past day but down over the past week, month, past 3 months and year. See our latest analysis for Azenta. That 1.8% one day share price gain comes after a tougher stretch, with a 30 day share price return of 28.45% and a 1 year total shareholder return of 36.97%. This suggests momentum has been fading rather than building. If Azenta's recent weakness has you...

Exelixis recently reported past fourth-quarter 2025 revenue of US$598.66 million and net income of US$244.53 million, with full-year 2025 revenue of US$2.32 billion and net income of US$782.57 million, alongside higher basic and diluted earnings per share from continuing operations versus the prior year. At the same time, the FDA accepted Exelixis’s New Drug Application for zanzalintinib plus atezolizumab in previously treated metastatic colorectal cancer, signaling regulatory progress that...

In recent months, Quantum Computing Inc. completed the US$110.0 million cash acquisition of Luminar Semiconductor, expanding its photonic technology portfolio, patent base and engineering capabilities to better address government and defense-related demand. At the same time, Quantum Computing Inc. has become one of the most heavily shorted mid-to-mega cap technology names, with very large short interest intensifying attention on its limited revenues, frequent equity raises and insider...

Relay Therapeutics recently announced that the U.S. FDA granted Breakthrough Therapy designation to its PI3Kα inhibitor zovegalisib (RLY-2608) in combination with fulvestrant for adults with PIK3CA‑mutant HR+/HER2‑ locally advanced or metastatic breast cancer after CDK4/6 inhibitor treatment, supported by Phase 1/2 ReDiscover trial data and an ongoing Phase 3 study. This regulatory milestone not only accelerates FDA feedback and review timelines but also highlights zovegalisib’s potential...

Blackbaud (BLKB) has just reported a return to profitability for both the fourth quarter and full year 2025, achieved its Rule of 40 goal earlier than planned, and issued new revenue guidance for 2026. See our latest analysis for Blackbaud. Despite the earnings rebound and early Rule of 40 achievement, Blackbaud’s recent share price performance has been weak, with a 30 day share price return showing an 11.54% decline and a 1 year total shareholder return showing a 38.56% loss. This suggests...

If you are looking at Louisiana-Pacific and asking whether the current share price lines up with the underlying business, you are in the right place. The stock closed at US$93.62, with a 5.0% decline over the last 7 days, a 0.5% return over 30 days, a 14.5% return year to date, and returns of a 15.7% decline over 1 year, 50.3% over 3 years, and 110.4% over 5 years. These mixed returns hint that the market has been reassessing both the potential and the risks around Louisiana-Pacific. To...

In February 2026, International Flavors & Fragrances Inc. reported mixed fourth-quarter 2025 results, with sales of US$2,589 million down from US$2,771 million a year earlier, a swing to full-year 2025 net loss of US$374 million, and issued 2026 sales guidance of US$10.50–US$10.80 billion alongside adjusted EBITDA guidance of US$2.05–US$2.15 billion. At the same time, IFF accelerated its portfolio reshaping by launching a formal sale process for its Food Ingredients business and outlining a...